Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →
NeuroThera Labs completes C$5.4 million financing with significant participation from SciSparc, strengthening its position in the clinical-stage pharmaceutical sector.
PRIVATEAug 18, 2026•about 4 hours ago
Amount Raised
$5.4 Million
Round Type
Seed
Investors
Sci Sparc Ltd.
Description
NeuroThera Labs has raised C$5.4 million through two tranches of private placements, with SciSparc investing C$2.7 million. This financing enables NeuroThera to enhance its working capital for ongoing pharmaceutical development. Following this round, SciSparc holds a 44.6% stake in NeuroThera, valued at approximately C$30 million.
Don't miss Neurothera Labs's next move
Get an email the moment Neurothera Labs raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers